Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AA, Achillion, Algisyl, Alliance, anatomical, anemia, Ansbacher, antiseptic, aplastic, Arog, attack, automobile, Avenue, Baxter, Bayer, beta, BioMed, BMS, Bortezomib, BPCIA, bright, Broadfin, burixafor, CardioFit, Cardiomyopathy, catheterization, Cayman, Celera, characteristic, childproofed, circumstance, clarify, cohesive, Construction, conventional, converged, core, Cornerstone, crenolanib, crucial, CTI, dasatinib, depict, depleted, deployment, diarrhea, disclaim, distance, dripping, easy, echocardiography, Edge, electro, English, ergonomic, Etrolizumab, expressly, Fabre, feet, Finnish, fundamentalist, Ganetespib, Gestion, gram, Grand, Harvoni, hATG, HaYehudim, HeartNet, Herzliya, holiday, hypoplastic, ibrutinib, immature, immunosuppressive, insurrection, Integra, interchangeable, IP, Iraq, irrevocable, Islamic, Jacksonville, JSC, Kappaproct, Karyopharm, Kevin, killing, Kotler, larger, Lessee, leukemic, Lichtstrasse, Lipid, lirilumab, lowest, LVR, Medarex, median, Medinat, Medivation, merit, mesh, midst, monotherapy, myelodysplastic, Nexavar, nintedanib, NV, OCI, oligo, Omega, OTC, overcompensation, owe, pacritinib, Pak, Parliament, pecuniary, Perrigo, pharmacodynamic, physician, pidilizumab, Pierre, plasma, Plc, Polyphor, prednisone, premarket, progenitor, proliferation, Protalix, recombinant, recuperation, regeneration, rental, restore, restraining, revealed, Rheumatology, Rich, ROFN, segment, selinexor, Solomon, sonidegib, sorafenib, specialist, Sprycel, standstill, steering, Stemline, subtype, Supervisory, swift, Symbio, symptomatic, Synta, TaiGen, thin, thoracotomy, Tohmatsu, tool, top, tosedostat, Touche, turmoil, Ulocuplumab, unblinded, unintentional, upcoming, urine, Valley, Valvira, venetoclax, Viekira, violence, walk, workload, wound, zone
Removed:
anterior, bid, BioHeart, BSI, chamber, collateralized, conferring, contact, convenient, CorCapTM, cream, deploy, Disclofenac, discomfort, doubled, enlargement, eventually, Fedak, fell, forgive, formed, HeartNetTM, Imiquimod, implantation, infarcted, intracoronary, irreversible, itching, journal, lend, mild, MyoCell, negotiate, organizing, originate, outfitting, Paracor, Paul, persistent, pledge, progressed, repair, scarred, sodium, sooner, staffing, sterile, suffering, sum, unavailable, violate, winding
Filing tables
Filing exhibits
BLRX similar filings
Filing view
External links
Exhibit 15.5
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-176419, 333-183976 and 333-201326) and on Form F-3 (Nos. 333-179792 and 333-182997) of BIOLINERX LTD. (the “Company”), of our report dated March 23, 2015, relating to the financial statements of the Company, which appears in this Form 20-F.
Tel-Aviv, Israel March 23, 2015 | /s/ Kesselman & Kesselman Certified Public Accountants (Isr.) A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 68125, Israel, P.O Box 452 Tel-Aviv 61003 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.co.il
Kesselman & Kesselman is a member firm of PricewaterhouseCoopers International Limited, each member firm of which is a separate legal entity